Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | FDPS | P14324 | 5/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.45 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.45 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.45 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.45 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2457756 | 0.79 | KMT2A (0.43) | ALDH1A1FDPSMAPK1HDAC3HDAC4 | |
| SCHEMBL2598121 | 0.78 | FDPS (0.42) | ALDH1A1FDPS | |
| SCHEMBL2513707 | 0.77 | ALDH1A1 (0.62) | ALDH1A1FDPSMAPK1HDAC3HDAC4 | |
| SCHEMBL10484334 | 0.77 | HDAC3 (0.52) | ALDH1A1FDPSHDAC3HDAC4HDAC1 | |
| SCHEMBL7165932 | 0.77 | FDPS (0.52) | ALDH1A1FDPSMAPK1HDAC3HDAC4 | |
| SCHEMBL8915911 | 0.77 | HDAC1 (0.44) | ALDH1A1FDPSMAPK1HDAC3HDAC4 | |
| SCHEMBL8918701 | 0.77 | HDAC1 (0.44) | ALDH1A1FDPSMAPK1HDAC3HDAC4 | |
| SCHEMBL5694457 | 0.75 | ALDH1A1 (0.58) | ALDH1A1MAPK1HDAC3HDAC4HDAC1 | |
| SCHEMBL8914859 | 0.74 | FDPS (0.50) | ALDH1A1FDPSMAPK1HDAC3HDAC4 | |
| SCHEMBL8916211 | 0.74 | ANPEP (0.58) | HDAC3HDAC4HDAC1HDAC7HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110224128-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCULAR DYSTROPHY | WHALEN ANNE | 2011-09-15 | — | — | US | disclosed |
| US-4876248-A | Anti-inflammatory products derived from methylene-diphosphonic acid, and process for their preparation | SANOFI (FR) | 1989-10-24 | — | — | US | disclosed |
| US-4746654-A | ANTIARTHRITIC | SANOFI (FR) | 1988-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110224128-A1 | METHODS AND COMPOSITIONS FOR TREATMENT OF MUSCULAR DYSTROPHY | PYGM, TNNC1, MYOF | ALDH1A1 3179/4885FDPS 2668/4885MAPK1 4499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.